MA51082A - Un sel de sodium du n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide - Google Patents
Un sel de sodium du n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamideInfo
- Publication number
- MA51082A MA51082A MA051082A MA51082A MA51082A MA 51082 A MA51082 A MA 51082A MA 051082 A MA051082 A MA 051082A MA 51082 A MA51082 A MA 51082A MA 51082 A MA51082 A MA 51082A
- Authority
- MA
- Morocco
- Prior art keywords
- indacen
- hexahydro
- sulfonamide
- pyrazole
- carbamoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1806578.9A GB201806578D0 (en) | 2018-04-23 | 2018-04-23 | Novel compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51082A true MA51082A (fr) | 2021-05-19 |
Family
ID=62236309
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA48051A MA48051B1 (fr) | 2018-04-23 | 2019-04-23 | Un sel de sodium du n-((1,2,3,5,6,7-hexahydro-s-indacen-4 -yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide |
| MA051082A MA51082A (fr) | 2018-04-23 | 2019-04-23 | Un sel de sodium du n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA48051A MA48051B1 (fr) | 2018-04-23 | 2019-04-23 | Un sel de sodium du n-((1,2,3,5,6,7-hexahydro-s-indacen-4 -yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US10973803B2 (fr) |
| EP (2) | EP3606909B1 (fr) |
| JP (1) | JP7382958B2 (fr) |
| KR (1) | KR20210005589A (fr) |
| CN (1) | CN112020495B (fr) |
| AR (1) | AR114827A1 (fr) |
| AU (1) | AU2019257973A1 (fr) |
| BR (1) | BR112020021650A2 (fr) |
| CA (1) | CA3097832A1 (fr) |
| CY (1) | CY1123260T1 (fr) |
| DK (1) | DK3606909T3 (fr) |
| ES (1) | ES2811228T3 (fr) |
| GB (1) | GB201806578D0 (fr) |
| HR (1) | HRP20201263T1 (fr) |
| HU (1) | HUE050369T2 (fr) |
| LT (1) | LT3606909T (fr) |
| MA (2) | MA48051B1 (fr) |
| MD (1) | MD3606909T2 (fr) |
| ME (1) | ME03822B (fr) |
| MX (1) | MX2020011196A (fr) |
| PL (1) | PL3606909T3 (fr) |
| PT (1) | PT3606909T (fr) |
| RS (1) | RS60646B1 (fr) |
| SI (1) | SI3606909T1 (fr) |
| TW (1) | TW201943704A (fr) |
| UY (1) | UY38186A (fr) |
| WO (1) | WO2019206871A1 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20190356A (es) | 2017-01-23 | 2019-11-20 | Genentech Inc | Compuestos químicos como inhibidores de la actividad de la interleuquina-1 |
| US11840543B2 (en) | 2017-05-24 | 2023-12-12 | The University Of Queensland | Compounds and uses |
| US11370776B2 (en) | 2017-07-07 | 2022-06-28 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
| JP2020531448A (ja) | 2017-08-15 | 2020-11-05 | インフレイゾーム リミテッド | 新規なスルホンアミドカルボキサミド化合物 |
| US11926600B2 (en) | 2017-08-15 | 2024-03-12 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
| WO2019034692A1 (fr) | 2017-08-15 | 2019-02-21 | Inflazome Limited | Sulfonylurées et sulfonylthiourées en tant qu'inhibiteurs de nlrp3 |
| JP2020531453A (ja) | 2017-08-15 | 2020-11-05 | インフレイゾーム リミテッド | Ｎｌｒｐ３阻害剤としてのスルホニルウレアおよびスルホニルチオウレア |
| US11518739B2 (en) | 2017-08-15 | 2022-12-06 | Inflazome Limited | Sulfonamide carboxamide compounds |
| EP3707134A1 (fr) | 2017-11-09 | 2020-09-16 | Inflazome Limited | Nouveaux composés de sulfonamide carboxamide |
| WO2019166629A1 (fr) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Nouveaux composés |
| WO2019166627A1 (fr) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Nouveaux composés |
| WO2019166619A1 (fr) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Nouveaux composés |
| WO2019166632A1 (fr) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Nouveaux composés |
| US11884645B2 (en) | 2018-03-02 | 2024-01-30 | Inflazome Limited | Sulfonyl acetamides as NLRP3 inhibitors |
| GB201806578D0 (en) | 2018-04-23 | 2018-06-06 | Inflazome Ltd | Novel compound |
| EP3823726A1 (fr) | 2018-07-20 | 2021-05-26 | F. Hoffmann-La Roche SA | Composés de sulfonylurée en tant qu'inhibiteurs de l'activité de l'interleukine 1 |
| GB201817038D0 (en) | 2018-10-19 | 2018-12-05 | Inflazome Ltd | Novel processes |
| JP2023501319A (ja) * | 2019-11-07 | 2023-01-18 | インフレイゾーム リミテッド | 神経変性疾患の処置および予防 |
| WO2021089781A1 (fr) * | 2019-11-07 | 2021-05-14 | Inflazome Limited | Traitement ou prévention de troubles cérébraux psychiatriques faisant appel à l'inhibiteur de nlrp3 n-((1,2,3,4-hexahydro-s-indacène-4-yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide |
| CN114599356A (zh) * | 2019-11-07 | 2022-06-07 | 英夫拉索姆有限公司 | 自身炎症性病症的治疗 |
| GB201916237D0 (en) * | 2019-11-07 | 2019-12-25 | Inflazome Ltd | Novel treatment |
| EP4054563A1 (fr) | 2019-11-07 | 2022-09-14 | Inflazome Limited | Traitement et prévention d'une neuroinflammation ou d'un trouble encéphalique inflammatoire |
| WO2021089776A1 (fr) * | 2019-11-07 | 2021-05-14 | Inflazome Limited | Traitement et prévention d'un trouble cérébral traumatique |
| WO2022023907A1 (fr) | 2020-07-31 | 2022-02-03 | Novartis Ag | Méthodes de sélection et de traitement de patients présentant un risque élevé d'événements cardiaques indésirables majeurs |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4802908A (en) * | 1987-01-22 | 1989-02-07 | E. I. Du Pont De Nemours And Company | Herbicidal 2-(1H)-pyrazinones |
| WO2001019390A1 (fr) * | 1999-09-14 | 2001-03-22 | Pfizer Products Inc. | Traitement combine au moyen de il-1ra et de composes de diarylsulfonyluree |
| WO2013031931A1 (fr) * | 2011-09-02 | 2013-03-07 | 協和発酵キリン株式会社 | Régulateur d'activité de récepteur de chimiokine |
| US10538487B2 (en) * | 2015-02-16 | 2020-01-21 | The University Of Queensland | Sulfonylureas and related compounds and use of same |
| FR3046933B1 (fr) | 2016-01-25 | 2018-03-02 | Galderma Research & Development | Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires |
| BR112018016671A2 (pt) | 2016-02-16 | 2018-12-26 | The University Of Queensland | sulfonilureias e compostos relacionados e uso do mesmo |
| EP3872070A1 (fr) | 2016-04-18 | 2021-09-01 | Novartis AG | Composés et compositions pour traiter des états associés à une activité de nlrp |
| ES2940611T3 (es) | 2016-04-18 | 2023-05-09 | Novartis Ag | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP |
| EP3272739A1 (fr) | 2016-07-20 | 2018-01-24 | NodThera Limited | Derives de sulfonyluree et leur application en matiere de regulation de l'activite de l'interleukine-1 |
| GB201806578D0 (en) | 2018-04-23 | 2018-06-06 | Inflazome Ltd | Novel compound |
| GB201817038D0 (en) | 2018-10-19 | 2018-12-05 | Inflazome Ltd | Novel processes |
-
2018
- 2018-04-23 GB GBGB1806578.9A patent/GB201806578D0/en not_active Ceased
-
2019
- 2019-04-23 CN CN201980026640.0A patent/CN112020495B/zh active Active
- 2019-04-23 KR KR1020207030023A patent/KR20210005589A/ko not_active Application Discontinuation
- 2019-04-23 MA MA48051A patent/MA48051B1/fr unknown
- 2019-04-23 ES ES19721230T patent/ES2811228T3/es active Active
- 2019-04-23 SI SI201930005T patent/SI3606909T1/sl unknown
- 2019-04-23 RS RS20200936A patent/RS60646B1/sr unknown
- 2019-04-23 CA CA3097832A patent/CA3097832A1/fr active Pending
- 2019-04-23 PT PT197212301T patent/PT3606909T/pt unknown
- 2019-04-23 EP EP19721230.1A patent/EP3606909B1/fr active Active
- 2019-04-23 EP EP20176198.8A patent/EP3722281A1/fr not_active Withdrawn
- 2019-04-23 ME MEP-2020-173A patent/ME03822B/fr unknown
- 2019-04-23 WO PCT/EP2019/060311 patent/WO2019206871A1/fr unknown
- 2019-04-23 MA MA051082A patent/MA51082A/fr unknown
- 2019-04-23 MX MX2020011196A patent/MX2020011196A/es unknown
- 2019-04-23 HU HUE19721230A patent/HUE050369T2/hu unknown
- 2019-04-23 PL PL19721230T patent/PL3606909T3/pl unknown
- 2019-04-23 MD MDE20200181T patent/MD3606909T2/ro unknown
- 2019-04-23 UY UY0001038186A patent/UY38186A/es not_active Application Discontinuation
- 2019-04-23 LT LTEP19721230.1T patent/LT3606909T/lt unknown
- 2019-04-23 BR BR112020021650-0A patent/BR112020021650A2/pt not_active Application Discontinuation
- 2019-04-23 TW TW108114167A patent/TW201943704A/zh unknown
- 2019-04-23 DK DK19721230.1T patent/DK3606909T3/da active
- 2019-04-23 AR ARP190101056A patent/AR114827A1/es unknown
- 2019-04-23 AU AU2019257973A patent/AU2019257973A1/en not_active Abandoned
- 2019-04-23 JP JP2020557902A patent/JP7382958B2/ja active Active
-
2020
- 2020-04-16 US US16/850,978 patent/US10973803B2/en active Active
- 2020-08-11 HR HRP20201263TT patent/HRP20201263T1/hr unknown
- 2020-08-12 CY CY20201100756T patent/CY1123260T1/el unknown
-
2021
- 2021-03-09 US US17/196,956 patent/US20210315862A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019206871A1 (fr) | 2019-10-31 |
| MA48051B1 (fr) | 2020-08-31 |
| EP3606909B1 (fr) | 2020-05-27 |
| LT3606909T (lt) | 2020-10-12 |
| US20210315862A1 (en) | 2021-10-14 |
| TW201943704A (zh) | 2019-11-16 |
| EP3606909A1 (fr) | 2020-02-12 |
| HUE050369T2 (hu) | 2020-11-30 |
| PL3606909T3 (pl) | 2020-11-16 |
| AU2019257973A1 (en) | 2020-11-19 |
| MX2020011196A (es) | 2020-11-13 |
| CA3097832A1 (fr) | 2019-10-31 |
| BR112020021650A2 (pt) | 2021-01-26 |
| RS60646B1 (sr) | 2020-09-30 |
| EP3722281A1 (fr) | 2020-10-14 |
| PT3606909T (pt) | 2020-07-09 |
| JP7382958B2 (ja) | 2023-11-17 |
| ES2811228T3 (es) | 2021-03-11 |
| UY38186A (es) | 2019-11-29 |
| CN112020495B (zh) | 2024-05-17 |
| MD3606909T2 (ro) | 2020-08-31 |
| KR20210005589A (ko) | 2021-01-14 |
| JP2021522195A (ja) | 2021-08-30 |
| US10973803B2 (en) | 2021-04-13 |
| DK3606909T3 (da) | 2020-08-24 |
| HRP20201263T1 (hr) | 2021-02-05 |
| SI3606909T1 (sl) | 2020-09-30 |
| US20200237723A1 (en) | 2020-07-30 |
| AR114827A1 (es) | 2020-10-21 |
| ME03822B (fr) | 2021-04-20 |
| GB201806578D0 (en) | 2018-06-06 |
| CY1123260T1 (el) | 2021-12-31 |
| CN112020495A (zh) | 2020-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA51082A (fr) | Un sel de sodium du n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide | |
| EA201790407A1 (ru) | Зонды для визуализации белка хантингтина | |
| DK3986890T3 (da) | Benzisoxazol-sulfonamid-derivater | |
| SG11202001164SA (en) | Novel sulfonamide carboxamide compounds | |
| HUE057414T2 (hu) | Új szulfonamid karboxamid vegyületek | |
| EA201891024A1 (ru) | Соединения-ингибиторы tank-связывающей киназы | |
| EA201890899A1 (ru) | Модуляторы фарнезоидного x-рецептора | |
| EA201792021A1 (ru) | Ингибитор jak | |
| EA201790400A1 (ru) | Зонды для визуализации белка хантингтина | |
| EA201790432A1 (ru) | Зонды для визуализации белка хантингтина | |
| DE112020002807A5 (de) | Kühlvorrichtung | |
| CL2021000426A1 (es) | Inhibidores de la interacción proteína-proteína keap1-nrf2. | |
| HK1259405A1 (zh) | N-[5-(3，5-二氟-苄基)-1h-吲唑-3-基]-4-(4-甲基-哌嗪-1-基)-2-(四氫吡喃-4-基氨基)-苯甲酰胺的新晶型 | |
| EA201790408A1 (ru) | Зонды для визуализации белка хантингтина | |
| JP1638163S (ja) | 内視鏡用プロセッサ | |
| DK3752497T3 (da) | P300/cbp-hat-hæmmere | |
| DK3610783T3 (da) | Billedkvalitetsbedømmelse | |
| EA201691265A1 (ru) | Соединения агонисты gpr142 | |
| DK3736810T3 (da) | Hovedskal | |
| IL277578A (en) | New salt forms of URAT-1 inhibitors | |
| ES2926922T8 (es) | Camilla de masaje vibratoria | |
| EA201692485A1 (ru) | Новая полиморфная форма n-[2-(6-фтор-1h-индол-3-ил)этил]-3-(2,2,3,3-тетрафторпропокси)бензиламина гидрохлорида для лечения болезни альцгеймера | |
| DK3507287T3 (da) | Substituerede N-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamid og N-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamidderivater P2X7 receptorantagonister | |
| EA201892424A1 (ru) | Гетероциклические амиды, пригодные в качестве модуляторов белков | |
| IT201900008391A1 (it) | Procedimento di preparazione del polimorfo f di sodio neridronato |